The development of cutaneous sarcoidosis after TNF-blockers therapy may probably be triggered by an initial exposure to a skin antigen and it has been suggested that Propionibacterium acnes may promote the skin immune response observed in sarcoidosis [58]. This evidence concerns the gene TNF and skin sarcoidosis.